yuichi yasukura, Santen (R);
Atsuya Miki, Alcon (R), Ellex (R), Kowa (R), Novartis (R), Otsuka (R), PfizerJapan (R), R-Tech (R), Santen (R), Senju (R), Topcon (R);
Tomoko Asai, None;
Yasushi Ikuno, Bayer (R), Novartis (R), Tomey (F), Topcon (F);
Naoyuki Maeda, Alcon (R), AMO (R), B+L (R), HOYA (R), Japanese Ministry of the Education, Culture, Sports, Science and Technology (F), Johnson & Johnson (R), Menicon (R), Otsuka (R), Pfizer (R), Santen (R), Senjyu (R), TOMEY (R), Topcon (F);
Kohji Nishida, Abbott medical Optics Japan (R), AMO (R), HOYA (R), J&J (R), Japanese Society for the Promotion of Science (F), Menicon (R), Ministry of education, culture, sports, science and Technology, Japan (F), Ministry of Health, Labor, and Welfare, Japan (F), MSD (R), National Institute of Biomedical Innovation Japan (F), NEDO (new energy and industrial technology development organization (F), Otsuka Pharmaceutical (F), Pfizer (F), Santen (R), Senjyu (R), Takeda (R), Wacamoto (F)